Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T ...

The following is a summary of “Circular RNA_0003489 reflects unfavorable treatment response and shortened survival in newly diagnosed multiple myeloma patients who receive bortezomib-based induction ...

Researchers have identified biomarkers that can predict disease progression in multiple sclerosis, which could lead to the ...

Here we conclude our discussion with David P. Carbone, MD, PhD, The Ohio State University, by addressing the importance of ...

RVPH RECOVER Vocal Biomarker Data On September 4, 2024, Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) held a k ey ...

The most common breast cancer is HER2-negative, so called because it has low amounts of one of the proteins that contribute ...

For years, many people with Alzheimer's disease have been diagnosed clinically and confirmed at autopsy. Now Alzheimer's ...

AstraZeneca has used artificial intelligence to devise a unique biomarker for its Daiichi Sankyo-partnered datopotamab ...

Lowered costs and incremental effectiveness could improve when using biomarker-guided selection for treatment of patients ...

The ALPS index effectively distinguishes individuals with SCD from those with normal cognition and is correlated with amyloid beta burden.

Researchers are studying how leukocyte telomere length may be associated with the progression of Friedreich's ataxia.

In short, these results revealed that both CRLF2 OE and CRLF2-d are correlated with poor prognosis in ALL patients.